Ankit Kansagra

WORK HISTORY

EDUCATION

SKILLS

ABOUT ANKIT KANSAGRA

With over 15 years of experience as a hematologist and oncologist, I am currently the Senior Medical Director at The Janssen Pharmaceutical Companies of Johnson & Johnson, where I lead the clinical drug development efforts for Bispecifics (Talquetamab and Teclistamab) in multiple myeloma. I provide medical and scientific expertise for internal cross-functional teams, interact with global regulatory bodies, and oversee the clinical research plans for Investigational New Drug applications and New Drug Applications.In addition to my role at Janssen, I am an Adjunct Professor of Medicine at UT Southwestern Medical Center, where I educate and mentor medicine and oncology trainees. I am honored to be the Eugene P. Frenkel M.D. Scholar of Clinical Medicine is a prestigious award that recognizes excellence in clinical care, research, and education. My research interests and work are at the intersection of oncology, drug and device development, bio-informatics/AI, and patient care. I have published over 50 articles in peer-reviewed journals and more than 100 presentations at national and international conferences. I have a strong track record of successfully acquiring grants, publishing research, and collaborating with industry partners to advance the science and practice of medicine in hematologic malignancies. My mission is to improve patients\' lives with oncological disease by developing novel and effective therapies and fostering a culture of learning and innovation.